HemaSphere
(Jun 2022)
P1195: A REAL WORLD EXPERIENCE OF COMBINED TREATMENT WITH ROMIDEPSIN AND AZACITIDINE IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA.
- M. Kalac,
- C. Tam,
- M. Goldfinger,
- Z. Xiao,
- S. Rajeeve,
- F. Montanari,
- J. Kanakry,
- O. O’Connor,
- E. Marchi
Affiliations
- M. Kalac
- 1 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States of America
- C. Tam
- 2 Department of Hematology, Peter MacCallum Cancer Centre, Melbourne, Australia
- M. Goldfinger
- 3 Department of Medicine, Albert Einstein College of Medicine
- Z. Xiao
- 3 Department of Medicine, Albert Einstein College of Medicine
- S. Rajeeve
- 1 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States of America
- F. Montanari
- 4 Department of Hematology, Yale University Cancer Center, New York
- J. Kanakry
- 5 Experimental Transplantation & Immunotherapy Branch, National Cancer Institute, Bethesda
- O. O’Connor
- 6 Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, United States of America
- E. Marchi
- 6 Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, United States of America
- DOI
-
https://doi.org/10.1097/01.HS9.0000847644.74540.4d
- Journal volume & issue
-
Vol. 6
pp.
1081
– 1082
WeChat QR code